RECURRENT JUVENILE MYELOMONOCYTIC LEUKEMIA

Clinical trials for RECURRENT JUVENILE MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT JUVENILE MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for RECURRENT JUVENILE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for kids with Tough-to-Treat leukemia

Disease control Recruiting now

This early-stage study is testing a new drug, imetelstat, combined with two standard chemotherapy drugs (fludarabine and cytarabine) in children and young adults. It aims to find the safest dose and see if this combination can help control three types of aggressive blood cancers …

Matched conditions: RECURRENT JUVENILE MYELOMONOCYTIC LEUKEMIA

Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

RECURRENT JUVENILE MYELOMONOCYTIC LEUKEMIA

Get alerted when new RECURRENT JUVENILE MYELOMONOCYTIC LEUKEMIA trials appear

New hope for kids with Tough-to-Treat leukemia